Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L David

Showing results (261-270 of 1,779) with videos related to

Pageof 178
Sort By:
Journal of Cataract and Refractive Surgery|July 29, 2008
Re: Pharmacokinetics and pharmacodynamics of nepafenac, amfenac, ketorolac, and bromfenacFrank A Bucci, L David Waterbury
Cardiology Clinics|June 20, 2006
Percutaneous coronary interventions: guidelines, short- and long-term results, and comparison with coronary artery bypass graftingJoaquin E Cigarroa, L David Hillis
Birth Defects Research. Part B, Developmental and Reproductive Toxicology|May 30, 2009
Micro-computed tomography and alizarin red evaluations of boric acid-induced fetal skeletal changes in Sprague-Dawley ratsL David Wise, Christopher T Winkelmann
The New England Journal of Medicine|May 22, 2009
Optimal management of acute coronary syndromesL David Hillis, Richard A Lange
Current Opinion in Microbiology|November 13, 2007
Rhoptries: an arsenal of secreted virulence factorsPeter J Bradley, L David Sibley
The New England Journal of Medicine|January 5, 2007
Primary PCI for myocardial infarction with ST-segment elevationEllen C Keeley, L David Hillis
The New England Journal of Medicine|November 16, 2006
Myocardial infarction and the open-artery hypothesisL David Hillis, Richard A Lange
Tubercle|March 1, 1972
Preliminary observations on the occurrence of a streptomycin R-factor in Mycobacterium smegmatis ATCC 607W D Jones, H L David
Annales D'Endocrinologie|January 1, 1979
Effects of 1.25 dihydroxycholecalciferol on calcium phosphorus and magnesium balance in preterm infantsJ Senterre, L David, B Salle
Lyon Medical|September 24, 1972
[Therapeutic trial in a children's hospital of a new orally administered form of cephalexin]B Betend, R Goddon, L David
Pageof 178

Showing results (261-270 of 1,779) with videos related to

Sort By:
Pageof 178
Journal of Cataract and Refractive Surgery|July 29, 2008
Re: Pharmacokinetics and pharmacodynamics of nepafenac, amfenac, ketorolac, and bromfenacFrank A Bucci, L David Waterbury
Cardiology Clinics|June 20, 2006
Percutaneous coronary interventions: guidelines, short- and long-term results, and comparison with coronary artery bypass graftingJoaquin E Cigarroa, L David Hillis
Birth Defects Research. Part B, Developmental and Reproductive Toxicology|May 30, 2009
Micro-computed tomography and alizarin red evaluations of boric acid-induced fetal skeletal changes in Sprague-Dawley ratsL David Wise, Christopher T Winkelmann
The New England Journal of Medicine|May 22, 2009
Optimal management of acute coronary syndromesL David Hillis, Richard A Lange
Current Opinion in Microbiology|November 13, 2007
Rhoptries: an arsenal of secreted virulence factorsPeter J Bradley, L David Sibley
The New England Journal of Medicine|January 5, 2007
Primary PCI for myocardial infarction with ST-segment elevationEllen C Keeley, L David Hillis
The New England Journal of Medicine|November 16, 2006
Myocardial infarction and the open-artery hypothesisL David Hillis, Richard A Lange
Tubercle|March 1, 1972
Preliminary observations on the occurrence of a streptomycin R-factor in Mycobacterium smegmatis ATCC 607W D Jones, H L David
Annales D'Endocrinologie|January 1, 1979
Effects of 1.25 dihydroxycholecalciferol on calcium phosphorus and magnesium balance in preterm infantsJ Senterre, L David, B Salle
Lyon Medical|September 24, 1972
[Therapeutic trial in a children's hospital of a new orally administered form of cephalexin]B Betend, R Goddon, L David
Pageof 178